Mechanisms of the Inhibition of Cytochrome P 450-Mediated Drug Oxidation by Therapeutic Agents
- 1 January 1987
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 18 (1) , 55-81
- https://doi.org/10.3109/03602538708998300
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compoundsChemico-Biological Interactions, 1983
- The interaction of arylalkylbenzimidazoles and related compounds with microsomal oxidationXenobiotica, 1983
- Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or .beta.-naphthoflavoneBiochemistry, 1982
- Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationshipsJournal of Medicinal Chemistry, 1982
- Inhibitors of Cytochrome P-450s and Their Mechanism of ActionDrug Metabolism Reviews, 1981
- Inhibition of oxidative drug metabolism in microsomesPharmacology & Therapeutics, 1980
- The Use of Animal Subcellular Fractions to Study Type I Metabolism of XenobioticsPublished by American Chemical Society (ACS) ,1979
- Steric factors in the inhibitory interaction of imidazoles with microsomal enzymesBiochemical Pharmacology, 1977
- Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivoBiochemical Pharmacology, 1974
- Imidazole derivatives—A new class of microsomal enzyme inhibitorsBiochemical Pharmacology, 1972